CN116672401A - 一种草本抗hpv妇科抑菌凝胶及其制备方法 - Google Patents
一种草本抗hpv妇科抑菌凝胶及其制备方法 Download PDFInfo
- Publication number
- CN116672401A CN116672401A CN202310728206.5A CN202310728206A CN116672401A CN 116672401 A CN116672401 A CN 116672401A CN 202310728206 A CN202310728206 A CN 202310728206A CN 116672401 A CN116672401 A CN 116672401A
- Authority
- CN
- China
- Prior art keywords
- parts
- hpv
- plant extract
- herbal
- gynecological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000001879 gelation Methods 0.000 title description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000419 plant extract Substances 0.000 claims abstract description 32
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 20
- 241001116389 Aloe Species 0.000 claims abstract description 20
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 20
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 20
- 229960001631 carbomer Drugs 0.000 claims abstract description 20
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 18
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 18
- 229940041616 menthol Drugs 0.000 claims abstract description 18
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims abstract description 18
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 16
- 229940046009 vitamin E Drugs 0.000 claims abstract description 16
- 239000011709 vitamin E Substances 0.000 claims abstract description 16
- 239000008213 purified water Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000220317 Rosa Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 241000411851 herbal medicine Species 0.000 claims abstract description 11
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 10
- 229920001503 Glucan Polymers 0.000 claims description 17
- 229960004418 trolamine Drugs 0.000 claims description 15
- 241000972672 Phellodendron Species 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 241000222122 Candida albicans Species 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 229940095731 candida albicans Drugs 0.000 claims description 9
- 241000191967 Staphylococcus aureus Species 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 230000003385 bacteriostatic effect Effects 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 239000000499 gel Substances 0.000 description 29
- 230000000694 effects Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 5
- 230000007803 itching Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000109329 Rosa xanthina Species 0.000 description 4
- 235000004789 Rosa xanthina Nutrition 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 208000028659 discharge Diseases 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 3
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 3
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010040830 Skin discomfort Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 229960002086 dextran Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- 208000037897 vulvar eczema Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000009608 Papillomavirus Infections Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- YWORCEHQVMOKDM-UHFFFAOYSA-H tricalcium;1-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O.[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O YWORCEHQVMOKDM-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000000003 vaginal tablet Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种草本抗hpv妇科抑菌凝胶及其制备方法,草本抗hpv妇科抑菌凝胶由下列重量份原料制成:植物提取物16‑30份、醋酸氯己定0.03‑0.25份、燕麦‑β葡聚糖0.1‑2份、薄荷脑2‑5份、维生素E2‑5份、卡波姆3‑6份、三乙醇胺2‑7份、纯化水50‑90份,所述植物提取物由玫瑰花6‑10份、苦参15‑25份、黄柏15‑25份、白芷10‑18份、蛇床子8‑20份、芦荟5‑10份组成。
Description
技术领域
本发明涉及妇科保健护理技术领域,具体涉及一种草本抗hpv妇科抑菌凝胶。
背景技术
妇科疾病是女性常见病、多发病。但由于许多人对妇科疾病缺乏应有的认识,缺乏对身体的保健,加之各种不良生活习惯等,使生理健康每况愈下,从病理上看,妇科病的成因可能是由于菌群失衡、粘膜破损、微环境破坏等等而造成的。
hpv是人乳头状病毒,约99%的宫颈癌患者伴有高危型hpv感染,是宫颈癌的元凶。hpv主要通过直接或间接接触污染物品或通过性传播感染人类,hpv感染具有宿主和组织特异性,只能感染人类的皮肤粘膜受损细胞。hpv感染这些细胞后,以少量的游离DNA状态潜伏在基底细胞内,实现免疫逃逸。当基底细胞不断分化、成熟、向粘膜表层迁移,hpv病毒就大量增殖。随着粘膜表层上皮细胞的凋亡,病毒颗粒大量释放到上皮表面,作为新的感染源可进一步加重感染。
目前针对hpv病毒引起的妇科疾病的治疗可以采用药物治疗,药物治疗主要是通过阴道给药,常用阴道给药的制剂类型主要有栓剂、凝胶剂、阴道片等,而现有的凝胶剂类型对人体皮肤刺激大,抑菌、抗hpv效果一般。
发明内容
本发明为解决上述技术问题,提供了一种草本抗hpv妇科抑菌凝胶,能够清洁阴道环境、预防感染和抑制hpv。
本发明采用的技术方案如下:
一种草本抗hpv妇科抑菌凝胶,由下列重量份原料制成:植物提取物16-30份、醋酸氯己定0.03-0.25份、葡聚糖0.1-2份、薄荷脑2-5份、维生素E2-5份、卡波姆3-6份、三乙醇胺2-7份、纯化水50-90份,所述植物提取物由玫瑰花6-10份、苦参15-25份、黄柏15-25份、白芷10-18份、蛇床子8-20份、芦荟5-10份组成。
在本发明一些实施中,草本抗hpv妇科抑菌凝胶由下列重量份原料制成:植物提取物16份、醋酸氯己定0.03份、葡聚糖0.1份、薄荷脑2份、维生素E2份、卡波姆3份、三乙醇胺2份、纯化水50份,所述植物提取物由玫瑰花6份、苦参15份、黄柏15份、白芷10份、蛇床子8份、芦荟5份组成。
在本发明一些实施中,草本抗hpv妇科抑菌凝胶由下列重量份原料制成:植物提取物23份、醋酸氯己定0.14份、葡聚糖1份、薄荷脑3.5份、维生素E3.5份、卡波姆4.5份、三乙醇胺5份、纯化水70份,所述植物提取物由玫瑰花8份、苦参20份、黄柏20份、白芷14份、蛇床子14份、芦荟7份组成。
在本发明一些实施中,草本抗hpv妇科抑菌凝胶由下列重量份原料制成:植物提取物30份、醋酸氯己定0.25份、葡聚糖2份、薄荷脑5份、维生素E5份、卡波姆6份、三乙醇胺7份、纯化水90份,所述植物提取物由玫瑰花10份、苦参25份、黄柏25份、白芷18份、蛇床子20份、芦荟10份组成。
在本发明一些实施中,所述葡聚糖采用燕麦-β葡聚糖。
在本发明一些实施中,抑菌类型包括:金黄色葡萄球菌、白色念珠菌和大肠杆菌。
草本抗hpv妇科抑菌凝胶的制备方法包括以下步骤:
S1:将卡波姆加入纯化水中,搅拌至完全溶解,得到第一混合溶液;
S2:向第一混合溶液中加入植物提取物,搅拌至完全溶解,得到第二混合溶液;
S3:向第二混合溶液中加入醋酸氯己定、燕麦-β葡聚糖、薄荷脑、维生素和三乙醇胺进行混合搅拌,搅拌成膏状,制备得到草本抗hpv妇科抑菌凝胶。
草本抗hpv妇科抑菌凝胶配方的主要功效:
玫瑰花:功能主治为理气解郁,和血散瘀,治肝胃气痛,新久风痹,吐血咯血,月经不调,赤白带下,痢疾,乳痈,肿毒。
苦参:味苦,性寒,归心、肝、胃、大肠、膀胱经,具有清热,燥湿,杀虫的作用。
黄柏:黄柏为芸香科植物黄皮树的树皮,具有清热燥湿、泻火除蒸和解毒疗疮等功效。
白芷:祛风,燥湿,消肿,止痛。治头痛,眉棱骨痛,齿痛,鼻渊,寒湿腹痛,肠风痔漏,赤白带下,痈疽疮疡,皮肤燥痒,疥癣。
蛇床子:味辛、苦,性温。有散寒祛风、温肾助阳、燥湿、杀虫、止痒之功能效。外治外阴湿疹、妇人阴痒、滴虫性阴道炎等疾病。
芦荟:芦荟为百合目、百合科的多年生常绿草本植物,含有多种维生素,具有使皮肤收敛、柔软化、保湿和消炎的性能。芦荟中的异柠檬酸钙等成份能促进微循环,强化细胞活力。
本发明提取玫瑰花、苦参、黄柏、白芷、蛇床子和芦荟多种植物的提取物,多种植物提取物协同作用,制备的草本抗hpv妇科抑菌凝胶对阴道具有较好的调节护理作用。
醋酸氯己定:具有消炎的作用,对部分葡萄球菌、变异链球菌、唾液链球菌、白色念珠菌、大肠埃希菌、厌氧丙酸菌呈高度敏感,适用于皮肤及粘膜的消毒、创面感染、阴道感染
燕麦-β葡聚糖:燕麦-β葡聚糖具有改善肠道功能,促进肠道有益菌的增值。
薄荷脑:作用于皮肤或粘膜,有清凉止痒作用。
维生素E:维生素E具有抗氧化、抗炎功效。
卡波姆:用作增稠剂。
三乙醇胺:消毒防腐药,具有相当强的广谱抑菌、杀菌作用。外用高效安全抗菌消毒剂,可以杀灭金黄色葡萄球菌,大肠杆菌和白色念珠菌。
本发明的有益效果:
本发明的草本抗hpv妇科抑菌凝胶包括玫瑰花、苦参、黄柏、白芷、蛇床子和芦荟多种植物提取物,其中天然植物中,玫瑰花和血散瘀,治月经不调,赤白带下;苦参可抗菌消炎,用于阴肿阴痒,外治滴虫性阴道炎;黄柏具有清热燥湿的功效;蛇床子可抗真菌,外治外阴湿疹、妇人阴痒等;芦荟有消毒杀菌的功效,外治湿癣。本发明的草本抗hpv妇科抑菌凝胶能够有效抑制白色念球菌、大肠杆菌、金黄色葡萄球菌引起的的皮肤不适及性生活前后的卫生护理,对阴道炎治疗有极好的疗效。多种天然植物提取物与醋酸氯己定、葡聚糖、薄荷脑、维生素E及卡波姆进行配伍,安全无副作用,能够清洁阴道环境、预防感染和抑制hpv,消除各种致病菌引起的妇科问题。
附图说明
图1为本发明实施例的草本抗hpv妇科抑菌凝胶制备方法的流程图。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
如图1所示,本发明实施例的一种草本抗hpv妇科抑菌凝胶,由下列重量份原料制成:
植物提取物16份、醋酸氯己定0.03份、葡聚糖0.1份、薄荷脑2份、维生素E2份、卡波姆3份、三乙醇胺2份、纯化水50份,所述植物提取物由玫瑰花6份、苦参15份、黄柏15份、白芷10份、蛇床子8份、芦荟5份组成。
在本发明的一个实施例中,所述葡聚糖采用燕麦-β葡聚糖。
在本发明的一个实施例中,草本抗hpv妇科抑菌凝胶抑菌的种类包括:金黄色葡萄球菌、白色念珠菌和大肠杆菌。
本发明实施例的一种草本抗hpv妇科抑菌凝胶的制备方法包括以下步骤:
S1:将卡波姆加入纯化水中,搅拌至完全溶解,得到第一混合溶液。
S2:向第一混合溶液中加入植物提取物,搅拌至完全溶解,得到第二混合溶液。
S3:向第二混合溶液中加入醋酸氯己定、葡聚糖、薄荷脑、维生素和三乙醇胺进行混合搅拌,搅拌成膏状,制备得到草本抗hpv妇科抑菌凝胶。
实施例2:
本发明实施例的一种草本抗hpv妇科抑菌凝胶,由下列重量份原料制成:
植物提取物23份、醋酸氯己定0.14份、葡聚糖1份、薄荷脑3.5份、维生素E3.5份、卡波姆4.5份、三乙醇胺5份、纯化水70份,所述植物提取物由玫瑰花8份、苦参20份、黄柏20份、白芷14份、蛇床子14份、芦荟7份组成。
在本发明的一个实施例中,所述葡聚糖采用燕麦-β葡聚糖。
在本发明的一个实施例中,草本抗hpv妇科抑菌凝胶抑菌的种类包括:金黄色葡萄球菌、白色念珠菌和大肠杆菌。
本发明实施例的一种草本抗hpv妇科抑菌凝胶的制备方法与实施例1相同,这里不再进行赘述。
实施例3:
本发明实施例的一种草本抗hpv妇科抑菌凝胶,由下列重量份原料制成:
植物提取物30份、醋酸氯己定0.25份、葡聚糖2份、薄荷脑5份、维生素E5份、卡波姆6份、三乙醇胺7份、纯化水90份,所述植物提取物由玫瑰花10份、苦参25份、黄柏25份、白芷18份、蛇床子20份、芦荟10份组成。
在本发明的一个实施例中,所述葡聚糖采用燕麦-β葡聚糖。
在本发明的一个实施例中,草本抗hpv妇科抑菌凝胶抑菌的种类包括:金黄色葡萄球菌、白色念珠菌和大肠杆菌。
本发明实施例的一种草本抗hpv妇科抑菌凝胶的制备方法与实施例1相同,这里不再进行赘述。
本发明实施例1、实施例2和实施例3的草本抗hpv妇科抑菌凝胶的使用方法为:用于皮肤表面或阴道粘膜,去本发明产品适量用于妇女阴道擦拭或直接涂抹外阴,每晚睡前使用一次。使用时,皮肤破损处禁用,同时本发明产品也不能用于性生活中对性病的预防。
本发明实施例的草本抗hpv妇科抑菌凝胶包括玫瑰花、苦参、黄柏、白芷、蛇床子和芦荟多种植物提取物,其中天然植物中,玫瑰花和血散瘀,治月经不调,赤白带下;苦参可抗菌消炎,用于阴肿阴痒,外治滴虫性阴道炎;黄柏具有清热燥湿的功效;蛇床子可抗真菌,外治外阴湿疹、妇人阴痒等;芦荟有消毒杀菌的功效,外治湿癣。本发明的草本抗hpv妇科抑菌凝胶能够有效抑制白色念球菌、大肠杆菌、金黄色葡萄球菌引起的的皮肤不适及性生活前后的卫生护理,对阴道炎治疗有极好的疗效。多种天然植物提取物与醋酸氯己定、葡聚糖、薄荷脑、维生素E及卡波姆进行配伍,安全无副作用,能够清洁阴道环境、预防感染和抑制hpv,消除各种致病菌引起的妇科问题。
在本发明的描述中,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此,限定有“第一”、“第二”的特征可以明示或者隐含地包括一个或者更多个该特征。“多个”的含义是两个或两个以上,除非另有明确具体的限定。
在本发明中,除非另有明确的规定和限定,术语“安装”、“相连”、“连接”、“固定”等术语应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或成一体;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通或两个元件的相互作用关系。对于本领域的普通技术人员而言,可以根据具体情况理解上述术语在本发明中的具体含义。
在本发明中,除非另有明确的规定和限定,第一特征在第二特征“上”或“下”可以是第一和第二特征直接接触,或第一和第二特征通过中间媒介间接接触。而且,第一特征在第二特征“之上”、“上方”和“上面”可是第一特征在第二特征正上方或斜上方,或仅仅表示第一特征水平高度高于第二特征。第一特征在第二特征“之下”、“下方”和“下面”可以是第一特征在第二特征正下方或斜下方,或仅仅表示第一特征水平高度小于第二特征。
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不必针对相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任一个或多个实施例或示例中以合适的方式结合。此外,在不相互矛盾的情况下,本领域的技术人员可以将本说明书中描述的不同实施例或示例以及不同实施例或示例的特征进行结合和组合。
流程图中或在此以其他方式描述的任何过程或方法描述可以被理解为,表示包括一个或更多个用于实现特定逻辑功能或过程的步骤的可执行指令的代码的模块、片段或部分,并且本发明的优选实施方式的范围包括另外的实现,其中可以不按所示出或讨论的顺序,包括根据所涉及的功能按基本同时的方式或按相反的顺序,来执行功能,这应被本发明的实施例所属技术领域的技术人员所理解。
在流程图中表示或在此以其他方式描述的逻辑和/或步骤,例如,可以被认为是用于实现逻辑功能的可执行指令的定序列表,可以具体实现在任何计算机可读介质中,以供指令执行系统、装置或设备(如基于计算机的系统、包括处理器的系统或其他可以从指令执行系统、装置或设备取指令并执行指令的系统)使用,或结合这些指令执行系统、装置或设备而使用。就本说明书而言,“计算机可读介质”可以是任何可以包含、存储、通信、传播或传输程序以供指令执行系统、装置或设备或结合这些指令执行系统、装置或设备而使用的装置。计算机可读介质的更具体的示例(非穷尽性列表)包括以下:具有一个或多个布线的电连接部(电子装置),便携式计算机盘盒(磁装置),随机存取存储器(RAM),只读存储器(ROM),可擦除可编辑只读存储器(EPROM或闪速存储器),光纤装置,以及便携式光盘只读存储器(CDROM)。另外,计算机可读介质甚至可以是可在其上打印所述程序的纸或其他合适的介质,因为可以例如通过对纸或其他介质进行光学扫描,接着进行编辑、解译或必要时以其他合适方式进行处理来以电子方式获得所述程序,然后将其存储在计算机存储器中。
应当理解,本发明的各部分可以用硬件、软件、固件或它们的组合来实现。在上述实施方式中,多个步骤或方法可以用存储在存储器中且由合适的指令执行系统执行的软件或固件来实现。例如,如果用硬件来实现,和在另一实施方式中一样,可用本领域公知的下列技术中的任一项或他们的组合来实现:具有用于对数据信号实现逻辑功能的逻辑门电路的离散逻辑电路,具有合适的组合逻辑门电路的专用集成电路,可编程门阵列(PGA),现场可编程门阵列(FPGA)等。
本技术领域的普通技术人员可以理解实现上述实施例方法携带的全部或部分步骤是可以通过程序来指令相关的硬件完成,所述的程序可以存储于一种计算机可读存储介质中,该程序在执行时,包括方法实施例的步骤之一或其组合。
此外,在本发明各个实施例中的各功能单元可以集成在一个处理模块中,也可以是各个单元单独物理存在,也可以两个或两个以上单元集成在一个模块中。上述集成的模块既可以采用硬件的形式实现,也可以采用软件功能模块的形式实现。所述集成的模块如果以软件功能模块的形式实现并作为独立的产品销售或使用时,也可以存储在一个计算机可读取存储介质中。
尽管上面已经示出和描述了本发明的实施例,可以理解的是,上述实施例是示例性的,不能理解为对本发明的限制,本领域的普通技术人员在本发明的范围内可以对上述实施例进行变化、修改、替换和变型。
Claims (7)
1.一种草本抗hpv妇科抑菌凝胶,其特征在于,由下列重量份原料制成:
植物提取物16-30份、醋酸氯己定0.03-0.25份、葡聚糖0.1-2份、薄荷脑2-5份、维生素E2-5份、卡波姆3-6份、三乙醇胺2-7份、纯化水50-90份,所述植物提取物由玫瑰花6-10份、苦参15-25份、黄柏15-25份、白芷10-18份、蛇床子8-20份、芦荟5-10份组成。
2.根据权利要求1所述的草本抗hpv妇科抑菌凝胶,其特征在于,由下列重量份原料制成:
植物提取物16份、醋酸氯己定0.03份、葡聚糖0.1份、薄荷脑2份、维生素E2份、卡波姆3份、三乙醇胺2份、纯化水50份,所述植物提取物由玫瑰花6份、苦参15份、黄柏15份、白芷10份、蛇床子8份、芦荟5份组成。
3.根据权利要求1所述的草本抗hpv妇科抑菌凝胶,其特征在于,由下列重量份原料制成:
植物提取物23份、醋酸氯己定0.14份、葡聚糖1份、薄荷脑3.5份、维生素E3.5份、卡波姆4.5份、三乙醇胺5份、纯化水70份,所述植物提取物由玫瑰花8份、苦参20份、黄柏20份、白芷14份、蛇床子14份、芦荟7份组成。
4.根据权利要求1所述的草本抗hpv妇科抑菌凝胶,其特征在于,由下列重量份原料制成:
植物提取物30份、醋酸氯己定0.25份、葡聚糖2份、薄荷脑5份、维生素E5份、卡波姆6份、三乙醇胺7份、纯化水90份,所述植物提取物由玫瑰花10份、苦参25份、黄柏25份、白芷18份、蛇床子20份、芦荟10份组成。
5.根据权利要求1-4任一项所述的草本抗hpv妇科抑菌凝胶,其特征在于,所述葡聚糖采用燕麦-β葡聚糖。
6.根据权利要求5任一项所述的草本抗hpv妇科抑菌凝胶,其特征在于,抑菌类型包括:金黄色葡萄球菌、白色念珠菌和大肠杆菌。
7.根据权利要求6所述的草本抗hpv妇科抑菌凝胶,其特征在于,所述草本抗hpv妇科抑菌凝胶的制备方法包括以下步骤:
S1:将卡波姆加入纯化水中,搅拌至完全溶解,得到第一混合溶液;
S2:向第一混合溶液中加入植物提取物,搅拌至完全溶解,得到第二混合溶液;
S3:向第二混合溶液中加入醋酸氯己定、燕麦-β葡聚糖、薄荷脑、维生素和三乙醇胺进行混合搅拌,搅拌成膏状,制备得到草本抗hpv妇科抑菌凝胶。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310728206.5A CN116672401A (zh) | 2023-06-20 | 2023-06-20 | 一种草本抗hpv妇科抑菌凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310728206.5A CN116672401A (zh) | 2023-06-20 | 2023-06-20 | 一种草本抗hpv妇科抑菌凝胶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116672401A true CN116672401A (zh) | 2023-09-01 |
Family
ID=87779018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310728206.5A Withdrawn CN116672401A (zh) | 2023-06-20 | 2023-06-20 | 一种草本抗hpv妇科抑菌凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116672401A (zh) |
-
2023
- 2023-06-20 CN CN202310728206.5A patent/CN116672401A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103272153B (zh) | 一种抑菌凝胶及其制备方法 | |
CN102697961B (zh) | 一种治疗阴道炎的妇科清洗液及其制作方法 | |
CN113081928B (zh) | 一种植物抑菌凝胶及其制备方法和应用 | |
US10478463B2 (en) | External-use medicament for cleaning and care of the ovaries, vagina, and vulva | |
CN110604810A (zh) | 一种妇科用水解胶原蛋白凝胶剂及其制备方法 | |
CN103316262B (zh) | 一种妇科外用抗菌液及其制备方法 | |
CN113616714A (zh) | 一种高硒抗hpv病毒的生物蛋白凝胶敷料及其制备方法 | |
CN102861151B (zh) | 一种治疗褥疮的中药组合物 | |
KR20020062474A (ko) | 여성의 질염 및 냉대하증 치료효능을 갖는 한약재 조성물및 이를 이용하여 제조된 생리대 패드 | |
CN100544751C (zh) | 治疗臁疮的外用中成药及制作方法 | |
CN104288552A (zh) | 一种洁阴护理液及其制备方法 | |
CN111067971A (zh) | 一种治疗甲沟炎的中药组合物及其使用方法 | |
CN103007126A (zh) | 治疗霉菌性阴道炎的中药汤剂 | |
CN110393768A (zh) | 一种母猪子宫消炎的组合中药灌注药物及其制备方法和应用 | |
CN109602813A (zh) | 一种抑菌凝胶剂及其制备方法 | |
CN105106304A (zh) | 一种治疗妇科炎症的中药复方制剂及其制备方法 | |
CN116672401A (zh) | 一种草本抗hpv妇科抑菌凝胶及其制备方法 | |
CN108938703A (zh) | 快速抗菌的妇科凝胶 | |
CN107536923A (zh) | 一种白花蛇舌草抗菌凝胶剂 | |
CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
CN102078546A (zh) | 一种妇科外用药水 | |
CN104623443A (zh) | 治疗皮肤糜烂的中药 | |
CN105106459A (zh) | 一种治疗浅度溃疡期压疮的中药凝胶剂及其制备方法 | |
CN104958613B (zh) | 一种治疗蕴毒腐溃型褥疮的中药组合物及其制备方法 | |
CN105168625B (zh) | 一种临床护理上用于治疗二、三期褥疮的中药涂膜剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230901 |
|
WW01 | Invention patent application withdrawn after publication |